Department of Bioengineering and Therapeutic Sciences

Data-driven drug dosing speeds tuberculosis treatment to four months

A large trial of a new drug regimen for tuberculosis, designed in part by School researchers, leads to a new WHO recommendation for treating the disease.

Science in the Time of Corona: Using Cryo-EM and collaboration to understand SARS-CoV-2 antibodies

QBI TV presents Science in the Time of Corona, a live show where scientists discuss how COVID-19 has evolved science. Moderated by Robin Marks of the UCSF Office of Communications, the discussion will highlight recent research conducted by the QBI Coronavirus Research Group.

Creating Healthy and Inclusive Spaces on Campus

Join us for the next session of the Equity & Inclusion Speaker Series.

Update from the Dean: Excellence amidst change

School leadership changes, our ongoing fight against COVID-19, and the latest accomplishments of students, faculty members, and staff members

Frontiers in Epigenetics and Chromatin: From Fundamentals to the Clinic

Organized by Drs. Danica Fujimori and Geeta Narlikar, QBI presents Frontiers in Epigenetics and Chromatin: From Fundamentals to the Clinic. The symposium will be held online on September 20–21, 2021.

Helium recycling project sets a new standard for sustainability at UCSF

The School is now recycling much of the helium used in its NMR facilities.

Regulatory DNA opens a window through time

Research on Neanderthal DNA reveals new details about our evolutionary cousins

Scientific Collaborations Across Borders: a QBI Fireside Chat

The Quantitative Biosciences Institute (QBI) at UCSF presents Scientific Collaborations Across Borders: a QBI Fireside Chat, co-organized by the Embassy of France in San Francisco.

Pages